Net sales for the quarter fell 2% to $1.95 billion, reflecting the ongoing impact of lapping incremental shipments from the prior year’s ERP system transition. While the GOJO acquisition contributed 10 points to top-line growth, organic sales declined 13% as retailers continued to work through inventory levels. Gross margin narrowed to 41.3%, pressured by lower volumes and costs associated with integrating the new health and hygiene portfolio.
In section Releases
Clorox Reports Fiscal 2026 Results Amid Strategic Transformation
The Clorox Company reported fourth-quarter results in line with expectations, as the consumer goods giant navigated a complex fiscal year defined by the final stages of a five-year digital transformation and the high-profile acquisition of GOJO Industries, the maker of Purell.
For the full fiscal year 2026, Clorox saw net sales dip 5% to $6.72 billion. Earnings were significantly impacted by transaction costs and the conclusion of a massive $580 million digital modernization project. Despite these headwinds, CEO Linda Rendle noted that the company has strengthened its foundation, pointing to a robust innovation pipeline that includes new launches across brands like Burt’s Bees and Glad. Looking ahead to fiscal 2027, the company forecasts a return to growth, with net sales expected to rise between 13% and 14%, fueled by the full integration of its expanded health platform and more favorable year-over-year comparisons.
Comments (0)
No comments yet. Be the first!